Increased risk of AEs with higher ritonavir concentrations

被引:0
|
作者
机构
关键词
Plasma Concentration; Drug Exposure; Ritonavir; Therapeutic Drug; Therapeutic Drug Monitoring;
D O I
10.2165/00128415-199907810-00007
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [2] Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
    Tuija H. Nieminen
    Nora M. Hagelberg
    Teijo I. Saari
    Mikko Neuvonen
    Pertti J. Neuvonen
    Kari Laine
    Klaus T. Olkkola
    European Journal of Clinical Pharmacology, 2010, 66 : 977 - 985
  • [3] Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
    Nieminen, Tuija H.
    Hagelberg, Nora M.
    Saari, Teijo I.
    Neuvonen, Mikko
    Neuvonen, Pertti J.
    Laine, Kari
    Olkkola, Klaus T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (10) : 977 - 985
  • [9] Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
    Clarke, Robert
    Peden, John
    Hopewell, Jemma
    Kyriakou, Theodosios
    Goel, Anuj
    Heath, Simon
    Parish, Sarah
    Barlera, Simona
    Grazia, Maria
    Negri, Mario
    Rust, Stephan
    Bennett, Derrick
    Silveira, Angela
    Malarstig, Anders
    Green, Fiona
    Lathrop, Mark
    Gigante, Bruna
    Leander, Karin
    de Faire, Ulf
    Seedorf, Udo
    Hamsten, Anders
    Collins, Rory
    Watkins, Hugh
    CIRCULATION, 2009, 120 (18) : S589 - S589